News Conference News AHA 2024 ENBALV: Edoxaban Matches Warfarin After Bioprosthetic Valve Surgery Yael L. Maxwell November 17, 2024
News Conference News CRT 2021 DOAC Use Increasing in Patients With Bioprosthetic Heart Valves Todd Neale March 08, 2021
News Conference News AHA 2020 Rivaroxaban an Option for Patients with Bioprosthetic Mitral Valves and A-fib Todd Neale November 14, 2020
News Daily News DOACs in Patients With Mitral Stenosis and A-fib: Analysis Suggests a Benefit Todd Neale March 12, 2019
News Opinion Conversations in Cardiology Conversations in Cardiology: Can a Patient With Tissue Valves Switch From Warfarin to a NOAC? November 16, 2018